Pituitary

, Volume 19, Issue 5, pp 496–502 | Cite as

Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing’s syndrome

  • G. Aranda
  • M. Careaga
  • F. A. Hanzu
  • I. Patrascioiu
  • P. Ríos
  • M. Mora
  • B. Morales-Romero
  • W. Jiménez
  • I. Halperin
  • G. Casals
Article

Abstract

Purpose

Urinary free cortisol (UFC) determination by highly specific methods as mass spectrometry instead of commercially available antibody-based immunoassays is increasingly recommended. However, clinical comparisons of both analytical approaches in the screening of Cushing’s syndrome (CS) are not available. The aim of this study was to evaluate the diagnostic value of mass spectrometry versus immunoassay measurements of 24 h-UFC in the screening of CS.

Methods

Cross-sectional study of 33 histologically confirmed CS patients: 25 Cushing’s disease, 5 adrenal CS and 3 ectopic CS; 92 non-CS patients; and 35 healthy controls. UFC by immunoassay (UFCxIA) and mass spectrometry (UFCxMS), urinary free cortisone (UFCo) and UFC:UFCo ratio were measured, together with creatinine-corrected values. Sensitivity, specificity, AUC and Landis and Koch concordance index were determined.

Results

AUC for UFCxIA and UFCxMS were 0.77 (CI 0.68–0.87) and 0.77 (CI 0.67–0.87) respectively, with a kappa coefficient 0.60 and strong Landis and Koch concordance index. The best calculated cutoff values were 359 nmol/24 h for UFCxIA (78 % sensitivity, 62 % specificity) and 258.1 nmol/24 h for UCFxMS (53 % sensitivity, 86 % specificity). The upper limit of UFCxIA and UCFxMS reference ranges were 344.7 and 169.5 nmol/24 h respectively. Sensitivity and specificity for CS diagnosis at these cutpoints were 84 and 56 % for UFCxIA and 81 and 54 % for UFCxMS.

Conclusions

According to our data, both methods present a very similar diagnostic value. However, results suggest that lower cutoff points for mass spectrometry may be necessary in order to improve clinical sensitivity.

Keywords

Cushing’s syndrome Urinary free cortisol Mass spectrometry Immunoassay 

References

  1. 1.
    Pivonello R, Faggiano A, Lombardi G, Colao A (2005) The metabolic syndrome and cardiovascular risk in Cushing’s syndrome. Endocrinol Metab Clin North Am 34:327–339CrossRefPubMedGoogle Scholar
  2. 2.
    Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367:1605–1617CrossRefPubMedGoogle Scholar
  3. 3.
    Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Raff H, Sharma ST, Nieman LK (2014) Physiological basis for the etiology, diagnosis and treatment of adrenal disorders: cushing’s syndrome, adrenal insufficiency, and congenital hyperplasia. Compr Physiol 4:739–769CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Raff H, Auchus R, Findling JW, Nieman LK (2015) Urine free cortisol in the diagnosis of Cushing’s syndrome: is it worth doing and if so, how? J Clin Endocrinol Metab 100:395–397CrossRefPubMedGoogle Scholar
  6. 6.
    Rosmalen JG, Kerma IP, Wüst S, van der Ley C, Visser ST, Snieder H, Bakker SJ (2014) 24 h urinary free cortisol in large-scale epidemiological studies: short-term and long-term stability and sources of variability. Psychoneuroendocrinology 47:10–16CrossRefPubMedGoogle Scholar
  7. 7.
    Fong BM, Tam S, Leung KS (2010) Improved liquid chromatography–tandem mass spectrometry method in clinical utility for the diagnosis of Cushing’s syndrome. Anal Bioanal Chem 396:783–790CrossRefPubMedGoogle Scholar
  8. 8.
    Wood L, Ducroq DH, Fraser HL, Gillingwater S, Evans C, Pickett AJ, Rees DW, John R, Turkes A (2008) Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography–mass spectrometry and two commercial immunoassays. Ann Clin Biochem 45:380–388CrossRefPubMedGoogle Scholar
  9. 9.
    Handelsman DJ, Wartofsky L (2013) Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab 98:3971–3973CrossRefPubMedGoogle Scholar
  10. 10.
    Aranda G, Enseñat J, Mora M, Puig-Domingo M, Martínez de Osaba MJ, Casals G, Verger E, Ribalta MT, Hanzu FA, Halperin I (2015) Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up. Pituitary 18:142–149CrossRefPubMedGoogle Scholar
  11. 11.
    Casals G, Marcos J, Pozo ÓJ, Aguilera P, Herrero C, To-Figueras J (2013) Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria. Clin Biochem 46:819–824CrossRefPubMedGoogle Scholar
  12. 12.
    Monaghan PJ, Keevil BG, Trainer PJ (2013) Mass spectrometry for the endocrine clinic-much to digest. Clin Endocrinol (Oxf) 78:344–346CrossRefGoogle Scholar
  13. 13.
    Turpeinene U, Hamalainen E (2013) Determination of cortisol in serum, saliva and urine. Best Pract Res Clin Endocrinol Metab 27:795–801CrossRefGoogle Scholar
  14. 14.
    Cecatto F, Antonelli G, Barbot M, Zilio M, Mazzai L, Gatti R, Zaninotto M, Mantero F, Boscaro M, Plebani M, Scaroni C (2014) The diagnostic performance of urinary free cortisol is better than the cortisol: cortisone ratio in detecting de novo Cushing’s syndrome: the use of a LC–MS/MS method in routine clinical practice. Eur J Endocrinol 171:1–7CrossRefGoogle Scholar
  15. 15.
    Taylor A, Keevil B, Huhtaniemi I (2015) Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow. Eur J Endocrinol 173:D1–D12CrossRefPubMedGoogle Scholar
  16. 16.
    Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121:496–504CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM (2008) Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 93:1553–1562CrossRefPubMedGoogle Scholar
  18. 18.
    Carroll T, Raff H, Findling JW (2009) Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 15:335–342CrossRefPubMedGoogle Scholar
  19. 19.
    Ceccato F, Barbot M, Zilio M, Frigo AC, Albiger N, Camozzi V, Antonelli G, Plebani M, Mantero F, Boscaro M, Scaroni C (2015) Screening test for Cushing’s syndrome: urinary free cortisol role measured by LC–MS/MS. J Clin Endocrinol Metab 100:3856–386120CrossRefPubMedGoogle Scholar
  20. 20.
    Cooper MS, Stewart PM (2009) 11β-Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus–pituitary–adrenal axis, metabolic syndrome, and inflammation. J Clin Endocrinol Metab 94:4645–4654CrossRefPubMedGoogle Scholar
  21. 21.
    Stiefel P, García-Morillo JS, Jimenez L, Pamies E, Miranda ML, Carneado J, Villar J, Leal-Cerro A (2002) Role of ketoconazole treatment in urinary free cortisol to cortisone and tetrahydrocortisol to tetrahydrocortisone ratios in non-ectopic Cushing syndrome. Endocrine 18:279–284CrossRefPubMedGoogle Scholar
  22. 22.
    Alexandraki KI, Grossman AB (2010) The ectopic ACTH syndrome. Rev Endocr Metab Disord 11:117–126CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • G. Aranda
    • 1
    • 2
  • M. Careaga
    • 2
  • F. A. Hanzu
    • 1
    • 2
    • 3
    • 4
  • I. Patrascioiu
    • 2
  • P. Ríos
    • 2
  • M. Mora
    • 1
    • 2
    • 3
    • 4
  • B. Morales-Romero
    • 5
  • W. Jiménez
    • 5
    • 6
  • I. Halperin
    • 1
    • 2
    • 3
    • 4
  • G. Casals
    • 5
  1. 1.Group of Endocrine DisordersIDIBAPSBarcelonaSpain
  2. 2.Department of Endocrinology and NutritionHospital ClinicBarcelonaSpain
  3. 3.Centro de Investigación en RedCIBERDEMBarcelonaSpain
  4. 4.University of BarcelonaBarcelonaSpain
  5. 5.Biochemistry and Molecular Genetics ServiceHospital Clinic Universitari, IDIBAPS, CIBERehdBarcelonaSpain
  6. 6.Biomedicine DepartmentUniversity of BarcelonaBarcelonaSpain

Personalised recommendations